Chiesi Group and VoiceMed launch pilot to advance early detection of chronic respiratory diseases through vocal biomarkers
January 13, 2026
VoiceMed and Chiesi collaborate on a pilot project to test vocal biomarkers in chronic respiratory diseases. Results highlight the potential of the technology for screening and monitoring, paving the way for integration into existing clinical workflows.